The NADPH oxidase and microbial killing by neutrophils, with a particular emphasis on the proposed antimicrobial role of myeloperoxidase within the phagocytic vacuole

Microbiology Spectrum

Volumn 4, Issue 4, 2016, Pages

  Levine, Adam P ^a   Segal, Anthony W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; BACTERIUM; CELL VACUOLE; DRUG EFFECTS; ENZYMOLOGY; FUNGUS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; NEUTROPHIL; OSMOLARITY; PH; PHYSIOLOGY;

ANIMALS; BACTERIA; FUNGI; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL VIABILITY; NADPH OXIDASE; NEUTROPHILS; OSMOLAR CONCENTRATION; PEROXIDASE; VACUOLES;

EID: 85011588765     PISSN: None     EISSN: 21650497     Source Type: Journal    
DOI: 10.1128/microbiolspec.MCHD-0018-2015     Document Type: Article

References (142)

1. Sbarra AJ, Karnovsky ML. 1959. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 234:1355-1362.
2. Klebanoff SJ, Hamon CB. 1972. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12:170-196.
3. Baehner RL, Gilman N, Karnovsky ML. 1970. Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies. J Clin Invest 49:692-700.
4. Zatti M, Rossi F. 1965. Early changes of hexose monophosphate pathway activity and of NADPH oxidation in phagocytizing leucocytes. Biochim Biophys Acta 99:557-561.
5. Berendes H, Bridges RA, Good RA. 1957. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med 40:309-312.
6. Bridges RA, Berendes H, Good RA. 1959. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 97:387-408.
7. McCord JM, Fridovich I. 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055.
8. Iyer GY, Islam DM, Quastel JH. 1961. Biochemical aspects of phagocytosis. Nature 192:535-541.
9. Segal AW, Jones OT, Webster D, Allison AC. 1978. Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet 2:446-449.
10. Segal AW, Jones OT. 1978. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 276:515-517.
11. Borregaard N, Johansen KS, Taudorff E, Wandall JH. 1979. Cytochrome b is present in neutrophils from patients with chronic granulomatous disease. Lancet 1:949-951.
12. Segal AW, Jones OT. 1980. Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous disease. FEBS Lett 110:111-114.
13. -245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326:88-91.
14. Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ. 1987. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91, 000 and 22, 000. J Clin Invest 80:732-742.
15. 558 of the NADPH oxidase of phagocytes. Biochem J 320(Pt 1):33-38.
16. phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 278:25234-25246.
17. Clark RA, Volpp BD, Leidal KG, Nauseef WM. 1990. Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 85:714-721.
18. Segal AW, Heyworth PG, Cockcroft S, Barrowman MM. 1985. Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44, 000 protein. Nature 316:547-549.
19. phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 296:557-561.
20. rac1. Nature 353:668-670.
21. Bromberg Y, Pick E. 1985. Activation of NADPH-dependent superoxide production in a cell-free system by sodium dodecyl sulfate. J Biol Chem 260:13539-13545.
22. Curnutte JT. 1985. Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system. J Clin Invest 75:1740-1743.
23. Curnutte JT, Scott PJ, Mayo LA. 1989. Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. Proc Natl Acad Sci U S A 86:825-829.
24. -245 from human neutrophils. Biochem J 219:519-527.
25. -245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. Biochem J 284:781-788.
26. Finegold AA, Shatwell KP, Segal AW, Klausner RD, Dancis A. 1996. Intramembrane bis-heme motif for transmembrane electron transport conserved in a yeast iron reductase and the human NADPH oxidase. J Biol Chem 271:31021-31024.
27. Wallach TM, Segal AW. 1997. Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J 321:583-585.
28. -245. Nature 327:720-721.
29. Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole FS, Curnutte JT, Orkin SH. 1986. Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location. Cold Spring Harbor Symp Quant Biol 51 (Pt 1):177-183.
30. Agner K. 1947. Detoxicating effect of verdoperoxidase on toxins. Nature 159:271-272.
31. Segal AW, Dorling J, Coade S. 1980. Kinetics of fusion of the cytoplasmic granules with phagocytic vacuoles in human polymorphonuclear leukocytes. Biochemical and morphological studies. J Cell Biol 85:42-59.
32. Klebanoff SJ. 1967. Iodination of bacteria: a bactericidal mechanism. J Exp Med 126:1063-1078.
33. Klebanoff SJ, White LR. 1969. Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N Engl J Med 280:460-466.
34. Babior BM, Kipnes RS, Curnutte JT. 1973. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741-744.
35. McCord JM, Wong K. 1979. Phagocyte-produced free radicals: roles in cytotoxicity and inflammation, p 343-360. In Fitzsimons DW (ed), Oxygen Free Radicals and Tissue Damage. Elsevier, North-Holland, Amsterdam, The Netherlands.
36. Ward PA. 1983. Role of toxic oxygen products from phagocytic cells in tissue injury. Adv Shock Res 10:27-34.
37. Greenwald RA. 1991. Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum 20:219-240.
38. Jacques YV, Bainton DF. 1978. Changes in pH within the phagocytic vacuoles of human neutrophils and monocytes. Lab Invest 39:179-185.
39. Klebanoff SJ. 1968. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95:2131-2138.
40. Levine AP, Duchen MR, de Villiers S, Rich PR, Segal AW. 2015. Alkalinity of neutrophil phagocytic vacuoles is modulated by HVCN1 and has consequences for myeloperoxidase activity. PLoS One 10:e0125906. doi:10.1371/journal.pone.0125906.
41. Götz F. 2002. Staphylococcus and biofilms. Mol Microbiol 43:1367-1378.
42. Loutet SA, Valvano MA. 2010. A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun 78:4088-4100.
43. Wei JR, Lai HC. 2006. N-Acylhomoserine lactone-dependent cell-tocell communication and social behavior in the genus Serratia. Int J Med Microbiol 296:117-124.
44. Mowat E, Williams C, Jones B, McChlery S, Ramage G. 2009. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? Med Mycol 47(Suppl 1):S120-S126.
45. Mathé L, Van Dijck P. 2013. Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet 59:251-264.
46. Cuperus RA, Muijsers AO, Wever R. 1986. The superoxide dismutase activity of myeloperoxidase; formation of compound III. Biochim Biophys Acta 871:78-84.
47. Briggs RT, Karnovsky ML, Karnovsky MJ. 1977. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases. J Clin Invest 59:1088-1098.
48. Kettle AJ, Winterbourn CC. 2001. A kinetic analysis of the catalase activity of myeloperoxidase. Biochemistry 40:10204-10212.
49. Clark RA, Borregaard N. 1985. Neutrophils autoinactivate secretory products by myeloperoxidase-catalyzed oxidation. Blood 65:375-381.
50. Vissers MC, Winterbourn CC. 1988. Oxidative inactivation of neutrophil granule proteinases: implications for neutrophil-mediated proteolysis. Basic Life Sci 49:845-848.
51. Messina CG, Reeves EP, Roes J, Segal AW. 2002. Catalase negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Lett 518:107-110.
52. phox-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest 101:1843-1850.
53. Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM. 2013. Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 93:185-198.
54. Jiang Q, Griffin DA, Barofsky DF, Hurst JK. 1997. Intraphagosomal chlorination dynamics and yields determined using unique fluorescent bacterial mimics. Chem Res Toxicol 10:1080-1089.
55. Koide Y, Urano Y, Hanaoka K, Terai T, Nagano T. 2011. Development of an Si-rhodamine-based far-red to near-infrared fluorescence probe selective for hypochlorous acid and its applications for biological imaging. J Am Chem Soc 133:5680-5682.
56. Painter RG, Valentine VG, Lanson NA, Jr, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G, Wang G. 2006. CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45:10260-10269.
57. Painter RG, Bonvillain RW, Valentine VG, Lombard GA, LaPlace SG, Nauseef WM, Wang G. 2008. The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J Leukoc Biol 83:1345-1353.
58. Chapman AL, Hampton MB, Senthilmohan R, Winterbourn CC, Kettle AJ. 2002. Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem 277:9757-9762.
59. Green JN, Kettle AJ, Winterbourn CC. 2014. Protein chlorination in neutrophil phagosomes and correlation with bacterial killing. Free Radic Biol Med 77:49-56.
60. Segal AW, Garcia RC, Harper AM, Banga JP. 1983. Iodination by stimulated human neutrophils. Studies on its stoichiometry, subcellular localization and relevance to microbial killing. Biochem J 210:215-225.
61. Reeves EP, Nagl M, Godovac-Zimmermann J, Segal AW. 2003. Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte. J Med Microbiol 52:643-651.
62. Cech P, Lehrer RI. 1984. Phagolysosomal pH of human neutrophils. Blood 63:88-95.
63. Cech P, Lehrer RI. 1984. Heterogeneity of human neutrophil phagolysosomes: functional consequences for candidacidal activity. Blood 64:147-151.
64. Paiva CN, Bozza MT. 2014. Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal 20:1000-1037.
65. Winterbourn CC, Kettle AJ. 2013. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid Redox Signal 18:642-660.
66. Hurst JK, Barrette WC, Jr. 1989. Leukocytic oxygen activation and microbicidal oxidative toxins. Crit Rev Biochem Mol Biol 24:271-328.
67. Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ. 1981. Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med 95:293-301.
68. Becker R, Pflüger KH. 1994. Myeloperoxidase deficiency: an epidemiological study and flow-cytometric detection of other granular enzymes in myeloperoxidase-deficient subjects. Ann Hematol 69:199-203.
69. Nunoi H, Kohi F, Kajiwara H, Suzuki K. 2003. Prevalence of inherited myeloperoxidase deficiency in Japan. Microbiol Immunol 47:527-531.
70. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Maeda N, Koyama H. 2000. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis 182:1276-1279.
71. Schapiro BL, Newburger PE, Klempner MS, Dinauer MC. 1991. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med 325:1786-1790.
72. Winkelstein JA, Marino MC, Johnston RB, Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169.
73. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Dinauer MC, Maeda N, Koyama H. 2002. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med Mycol 40:557-563.
74. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Dinauer MC, Maeda N, Koyama H. 2002. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J Infect Dis 185:1833-1837.
75. Lardner A. 2001. The effects of extracellular pH on immune function. J Leukoc Biol 69:522-530.
76. Wolach B, Gavrieli R, Roos D, Berger-Achituv S. 2012. Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections. J Clin Immunol 32:454-466.
77. Kolset SO, Gallagher JT. 1990. Proteoglycans in haemopoietic cells. Biochim Biophys Acta 1032:191-211.
78. Borregaard N, Cowland JB. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521.
79. Pham CT. 2006. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6:541-550.
80. Cohn ZA, Hirsch JG. 1960. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J Exp Med 112:983-1004.
81. Odeberg H, Olsson I. 1976. Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun 14:1269-1275.
82. Segal AW, Geisow M, Garcia R, Harper A, Miller R. 1981. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 290:406-409.
83. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. 2000. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12:201-210.
84. + flux. Nature 416:291-297.
85. Hahn I, Klaus A, Janze AK, Steinwede K, Ding N, Bohling J, Brumshagen C, Serrano H, Gauthier F, Paton JC, Welte T, Maus UA. 2011. Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice. Infect Immun 79:4893-4901.
86. Steinwede K, Maus R, Bohling J, Voedisch S, Braun A, Ochs M, Schmiedl A, Länger F, Gauthier F, Roes J, Welte T, Bange FC, Niederweis M, Bühling F, Maus UA. 2012. Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice. J Immunol 188:4476-4487.
87. Standish AJ, Weiser JN. 2009. Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol 183:2602-2609.
88. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD. 1998. Mice lacking neutrophil elastase reveal impaired host defense against Gram negative bacterial sepsis. Nat Med 4:615-618.
89. MacIvor DM, Shapiro SD, Pham CT, Belaaouaj A, Abraham SN, Ley TJ. 1999. Normal neutrophil function in cathepsin G-deficient mice. Blood 94:4282-4293.
90. Vethanayagam RR, Almyroudis NG, Grimm MJ, Lewandowski DC, Pham CT, Blackwell TS, Petraitiene R, Petraitis V, Walsh TJ, Urban CF, Segal BH. 2011. Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. PLoS One 6:e28149. doi:10.1371/journal.pone.0028149.
91. Sellers RS, Clifford CB, Treuting PM, Brayton C. 2012. Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol 49:32-43.
92. Hewitt C, McCormick D, Linden G, Turk D, Stern I, Wallace I, Southern L, Zhang L, Howard R, Bullon P, Wong M, Widmer R, Gaffar KA, Awawdeh L, Briggs J, Yaghmai R, Jabs EW, Hoeger P, Bleck O, Rüdiger SG, Petersilka G, Battino M, Brett P, Hattab F, Al-Hamed M, Sloan P, Toomes C, Dixon M, James J, Read AP, Thakker N. 2004. The role of cathepsin C in Papillon-Lefèvre syndrome, prepubertal periodontitis, and aggressive periodontitis. Hum Mutat 23:222-228.
93. Adkison AM, Raptis SZ, Kelley DG, Pham CTN. 2002. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 109:363-371.
94. Turk D, Janjic V, Stern I, Podobnik M, Lamba D, Dahl SW, Lauritzen C, Pedersen J, Turk V, Turk B. 2001. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J 20:6570-6582.
95. Pham CT, Ley TJ. 1999. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A 96:8627-8632.
96. Adkison AM, Raptis SZ, Kelley DG, Pham CT. 2002. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 109:363-371.
97. Sørensen OE, Clemmensen SN, Dahl SL, Østergaard O, Heegaard NH, Glenthøj A, Nielsen FC, Borregaard N. 2014. Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses. J Clin Invest 124:4539-4548.
98. Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ. 2004. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J Immunol 173:7277-7281.
99. Djawari D. 1978. Deficient phagocytic function in Papillon-Lefèvre syndrome. Dermatologica 156:189-192.
100. Ghaffer KA, Zahran FM, Fahmy HM, Brown RS. 1999. Papillon-Lefèvre syndrome: neutrophil function in 15 cases from 4 families in Egypt. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:320-325.
101. Clerehugh V, Drucker DB, Seymour GJ, Bird PS. 1996. Microbiological and serological investigations of oral lesions in Papillon-Lefèvre syndrome. J Clin Pathol 49:255-257.
102. de Haar SF, Hiemstra PS, van Steenbergen MT, Everts V, Beertsen W. 2006. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun 74:5284-5291.
103. Miyasaki KT, Bodeau AL. 1991. In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest 87:1585-1593.
104. de Haar SF, Tigchelaar-Gutter W, Everts V, Beertsen W. 2006. Structure of the periodontium in cathepsin C-deficient mice. Eur J Oral Sci 114:171-173.
105. Ansari-Lari MA, Kickler TS, Borowitz MJ. 2003. Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol 120:795-799.
106. Nauland U, Rijken DC. 1994. Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C). Eur J Biochem 223:497-501.
107. Sissons CH, Wong L, Shu M. 1998. Factors affecting the resting pH of in vitro human microcosm dental plaque and Streptococcus mutans biofilms. Arch Oral Biol 43:93-102.
108. Nauseef WM. 2014. Proteases, neutrophils, and periodontitis: the NET effect. J Clin Invest 124:4237-4239.
109. Jensen MS, Bainton DF. 1973. Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte. J Cell Biol 56:379-388.
110. Dri P, Presani G, Perticarari S, Albèri L, Prodan M, Decleva E. 2002. Measurement of phagosomal pH of normal and CGD-like human neutrophils by dual fluorescence flow cytometry. Cytometry 48:159-166.
111. Bernardo J, Long HJ, Simons ER. 2010. Initial cytoplasmic and phagosomal consequences of human neutrophil exposure to Staphylococcus epidermidis. Cytometry A 77:243-252.
112. + antiporter. J Leukoc Biol 45:239-248.
113. Hurst JK, Albrich JM, Green TR, Rosen H, Klebanoff S. 1984. Myeloperoxidase-dependent fluorescein chlorination by stimulated neutrophils. J Biol Chem 259:4812-4821.
114. Bassnett S, Reinisch L, Beebe DC. 1990. Intracellular pH measurement using single excitation-dual emission fluorescence ratios. Am J Physiol 258:C171-C178.
115. El Chemaly A, Nunes P, Jimaja W, Castelbou C, Demaurex N. 2014. Hv1 proton channels differentially regulate the pH of neutrophil and macrophage phagosomes by sustaining the production of phagosomal ROS that inhibit the delivery of vacuolar ATPases. J Leukoc Biol 95:1-13.
116. Jankowski A, Scott CC, Grinstein S. 2002. Determinants of the phagosomal pH in neutrophils. J Biol Chem 277:6059-6066.
117. Klebanoff SJ. 1970. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 169:1095-1097.
118. Hampton MB, Kettle AJ, Winterbourn CC. 1996. Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. Infect Immun 64:3512-3517.
119. Henderson LM, Chappell JB, Jones OT. 1988. Superoxide generation by the electrogenic NADPH oxidase of human neutrophils is limited by the movement of a compensating charge. Biochem J 255:285-290.
120. Ramsey IS, Ruchti E, Kaczmarek JS, Clapham DE. 2009. Hv1 proton channels are required for high-level NADPH oxidase-dependent superoxide production during the phagocyte respiratory burst. Proc Natl Acad Sci U S A 106:7642-7647.
121. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. 2010. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 62:726-759.
122. Magnani A, Brosselin P, Beauté J, de Vergnes N, Mouy R, Debré M, Suarez F, Hermine O, Lortholary O, Blanche S, Fischer A, Mahlaoui N. 2014. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol 134:655-662. e8. doi:10.1016/j.jaci.2014.04.014.
123. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. 2012. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol 2012:252460. doi:10.1155/2012/252460.
124. Schäppi MG, Jaquet V, Belli DC, Krause KH. 2008. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 30:255-271.
125. Kettle AJ, Anderson RF, Hampton MB, Winterbourn CC. 2007. Reactions of superoxide with myeloperoxidase. Biochemistry 46:4888-4897.
126. Feldmesser M. 2006. Role of neutrophils in invasive aspergillosis. Infect Immun 74:6514-6516.
127. phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894.
128. Lambeth JD. 2002. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol 9:11-17.
129. Bedard K, Lardy B, Krause KH. 2007. NOX family NADPH oxidases: not just in mammals. Biochimie 89:1107-1112.
130. Shatwell KP, Dancis A, Cross AR, Klausner RD, Segal AW. 1996. The FRE1 ferric reductase of Saccharomyces cerevisiae is a cytochrome b similar to that of NADPH oxidase. J Biol Chem 271:14240-14244.
131. Meitzler JL, Ortiz de Montellano PR. 2009. Caenorhabditis elegans and human dual oxidase 1 (DUOX1) "peroxidase" domains: insights into heme binding and catalytic activity. J Biol Chem 284:18634-18643.
132. Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W, Heinzmann U, Marquardt A, Bareiss A, Laufs J, Russ A, Stumm G, Schimenti JC, Bergstrom DE. 2004. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 18:486-491.
133. Trune DR. 2010. Ion homeostasis in the ear: mechanisms, maladies, and management. Curr Opin Otolaryngol Head Neck Surg 18:413-419.
134. Hibino H, Nin F, Tsuzuki C, Kurachi Y. 2010. How is the highly positive endocochlear potential formed? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch 459:521-533.
135. phox homologues AtrbohD and AtrbohF are required for accumulation of reactive oxygen intermediates in the plant defense response. Proc Natl Acad Sci U S A 99:517-522.
136. Potocký M, Jones MA, Bezvoda R, Smirnoff N, Zárský V. 2007. Reactive oxygen species produced by NADPH oxidase are involved in pollen tube growth. New Phytol 174:742-751.
137. Tavares B, Domingos P, Dias PN, Feijó JA, Bicho A. 2011. The essential role of anionic transport in plant cells: the pollen tube as a case study. J Exp Bot 62:2273-2298.
138. Montiel J, Arthikala MK, Quinto C. 2013. Phaseolus vulgaris RbohB functions in lateral root development. Plant Signal Behav 8:e22694. doi:10.4161/psb.22694.
139. Zhang H, Fang Q, Zhang Z, Wang Y, Zheng X. 2009. The role of respiratory burst oxidase homologues in elicitor-induced stomatal closure and hypersensitive response in Nicotiana benthamiana. J Exp Bot 60:3109-3122.
140. Tudzynski P, Heller J, Siegmund U. 2012. Reactive oxygen species generation in fungal development and pathogenesis. Curr Opin Microbiol 15:653-659.
141. Steinhubl SR. 2008. Why have antioxidants failed in clinical trials? Am J Cardiol 101:14D-19D.
142. Polidori MC, Nelles G. 2014. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease-challenges and perspectives. Curr Pharm Des 20:3083-3092.